|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/08 | (2006.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 38/16 | (2006.01) | ||
| A61K 38/26 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Patento numeris | 3541366 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17871296.4 |
| Europos patento paraiškos padavimo data | 2017-11-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-09-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-12-25 |
| (46) | Apibrėžties vertimo paskelbimo data | 2025-03-10 |
| (86) | Numeris | PCT/US2017/062838 |
| Data | 2017-11-21 |
| (87) | Numeris | WO 2018/094404 |
| Data | 2018-05-24 |
| (30) | Numeris | Data | Šalis |
| 201662424979 P | 2016-11-21 | US | |
| 201762517065 P | 2017-06-08 | US |
| (72) |
XIONG, Xiaofeng , US
ODINK, Debra , US
CRAIG, Colleen M. , US
SMITH, Christine M.N. , US
MCLAUGHLIN, Tracey L. , US
|
| (73) |
Amylyx Pharmaceuticals, Inc. ,
43 Thorndike St., Cambridge, MA 02141,
US
The Board of Trustees of the Leland Stanford Junior University , Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Eksendino (9-39) buferiniai preparatai |
| BUFFERED FORMULATIONS OF EXENDIN (9-39) |